Four New Drugs Are Around the Corner. Here’s What You Need to Know. | Ben Fidler | 08/15/19 | National |
Bio Roundup: Nobel Prizes, Duchenne Steps, Guardant’s IPO & More | Frank Vinluan | 10/05/18 | National |
Paratek Wins Two FDA Drug Approvals for Three Conditions in Same Day | Frank Vinluan | 10/03/18 | Boston |
Paratek Eyes FDA Approval of Antibiotic After Advisory Panel Nod | Jeff Bauter Engel | 08/08/18 | Boston |
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback | Ben Fidler | 02/14/18 | Boston |
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand | Frank Vinluan | 08/25/17 | National |
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data | Ben Fidler | 07/26/17 | Boston |
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More | Alex Lash | 07/21/17 | National |
Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs | Frank Vinluan | 04/25/17 | San Diego |
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals | Frank Vinluan | 04/06/17 | San Diego |
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval | Ben Fidler | 04/03/17 | Boston |
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More | Ben Fidler | 06/24/16 | National |
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle | Ben Fidler | 06/16/16 | Boston |
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” | Alex Lash | 12/02/14 | National |
Paratek Pharmaceuticals Receives $93,000,000 New Funding Round | VentureDeal | 07/15/14 | Boston |
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More | Bruce V. Bigelow | 07/03/14 | San Diego |
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News | Rebecca Zacks | 10/09/09 | Boston |
Paratek Pharmaceuticals Garners $18,000,000 New Financing | VentureDeal | 04/16/08 | Boston |
$40 Million for Paratek Pharmaceuticals | Rebecca Zacks | 10/25/07 | Boston |